Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

The ACR/ARHP Annual Meeting: Focus on Technology

Staff  |  October 1, 2012

Members of the American College of Rheumatology and Associate Rheumatology Health Professionals members can learn how to  incorporate the latest technological advances, including electronic health records, into their clinical practice

The ACR/ARHP Annual Meeting: Focus on Practice

Staff  |  October 1, 2012

Members of the American College of Rheumatology and Associate Rheumatology Health Professionals members can learn about strategies for managing and improving their clinical practice

The ACR/ARHP Annual Meeting: Focus on You

Staff  |  October 1, 2012

Members of the American College of Rheumatology and Associate Rheumatology Health Professionals can learn about the College’s activities and initiatives at the ACR Town Hall Meeting

ACR Resource Center Offers On-Site Expertise for Rheumatologists at ACR/ARHP Annual Meeting

Staff  |  October 1, 2012

ACR center staff will be on hand to answer all types of rheumatology-related questions

Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease

Thomas R. Collins  |  October 1, 2012

Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)

EULAR: Identify Arthritis Early, Treat it Effectively

Thomas R. Collins  |  October 1, 2012

Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis

Gender Reversal in the Field of Rheumatology

Ann Kepler  |  October 1, 2012

Behind rheumatology’s ongoing transformation from a specialty whose members are overwhelmingly male, to one that is overwhelmingly female

Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology

Gretchen Henkel  |  October 1, 2012

Career marked by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis

What Rheumatologists Should Know About Noncompetition Clauses

Steven M. Harris, Esq.  |  October 1, 2012

How rheumatologists can manage, and avoid, a restrictive noncompetition clause in an employment contract

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD  |  September 5, 2012

Relapses are common, but difficult to predict and prevent.

  • « Previous Page
  • 1
  • …
  • 249
  • 250
  • 251
  • 252
  • 253
  • …
  • 307
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences